# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001070081-20-000086
Filing Date
2020-04-27
Accepted
2020-04-27 16:15:31
Documents
5
Period of Report
2019-12-31
Effectiveness Date
2020-04-27

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | ptct2020proxy.htm | DEF 14A | 1367480
2 |  | dyera05.jpg | GRAPHIC | 15626
3 |  | g683229a01.jpg | GRAPHIC | 6822
4 |  | proxygraphicv2.jpg | GRAPHIC | 529744
5 |  | ptca01.jpg | GRAPHIC | 8644
| Complete submission text file | 0001070081-20-000086.txt |  | 2062930

Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35969 | Film No.: 20820132
SIC: 2834 Pharmaceutical Preparations